eCommons@AKU
Pathology, East Africa

Medical College, East Africa

2013

Malaria diagnosis and treatment practices following introduction
of rapid diagnostic tests in Kibaha District, Coast Region,
Tanzania
M. Mubi
Karolinska Institutet

D. Kakoko
Muhimbili University of Health and Allied Sciences

B. Ngasala
Muhimbili University of Health and Allied Sciences

Zul Premji
Aga Khan University, zul.premji@aku.edu

S. Peterson
Karolinska Institutet

See next page for additional authors

Follow this and additional works at: https://ecommons.aku.edu/eastafrica_fhs_mc_pathol
Part of the Pathology Commons

Recommended Citation
Mubi, M., Kakoko, D., Ngasala, B., Premji, Z., Peterson, S., Bjorkman, A., Martensson, A. (2013). Malaria
diagnosis and treatment practices following introduction of rapid diagnostic tests in Kibaha District,
Coast Region, Tanzania. Malaria Journal, 12(1), 1475-2875.
Available at: https://ecommons.aku.edu/eastafrica_fhs_mc_pathol/47

Authors
M. Mubi, D. Kakoko, B. Ngasala, Zul Premji, S. Peterson, A. Bjorkman, and A. Martensson

This article is available at eCommons@AKU: https://ecommons.aku.edu/eastafrica_fhs_mc_pathol/47

Mubi et al. Malaria Journal 2013, 12:293
http://www.malariajournal.com/content/12/1/293

RESEARCH

Open Access

Malaria diagnosis and treatment practices
following introduction of rapid diagnostic tests in
Kibaha District, Coast Region, Tanzania
Marycelina Mubi1,2*, Deodatus Kakoko3, Billy Ngasala2, Zul Premji2, Stefan Peterson4,5,6, Anders Björkman1
and Andreas Mårtensson1,4

Abstract
Background: The success of the universal parasite-based malaria testing policy for fever patients attending primary
health care (PHC) facilities in Tanzania will depend highly on health workers’ perceptions and practices. The aim of
this study was, therefore, to assess the present use of malaria diagnostics (rapid diagnostic tests (RDTs) and
microscopy), prescription behaviour and factors affecting adherence to test results at PHC facilities in Kibaha District,
Coast Region, Tanzania.
Methods: Exit interviews were conducted with fever patients at PHC facilities and information on diagnostic test
performed and treatment prescribed were recorded. Interviews with prescribers to assess their understanding,
perceptions and practices related to RDTs were conducted, and health facility inventory performed to assess
availability of staff, diagnostics and anti-malarial drugs.
Results: The survey was undertaken at ten governmental PHC facilities, eight of which had functional diagnostics.
Twenty health workers were interviewed and 195 exit interviews were conducted with patients at the PHC facilities.
Of the 168 patients seen at facilities with available diagnostics, 105 (63%) were tested for malaria, 31 (30%) of
whom tested positive. Anti-malarial drugs were prescribed to all patients with positive test results, 14% of patients
with negative results and 28% of patients not tested for malaria. Antibiotics were more likely to be prescribed to
patients with negative test results compared to patients with positive results (81 vs 39%, p < 0.01) and among nontested compared to those tested for malaria (84 vs 69%, p = 0.01). Stock-outs of RDTs and staff shortage accounted
for the low testing rate, and health worker perceptions were the main reason for non-adherence to test results.
Conclusions: Anti-malarial prescription to patients with negative test results and those not tested is still practiced
in Tanzania despite the universal malaria testing policy of fever patients. The use of malaria diagnostics was also
associated with higher prescription of antibiotics among patients with negative results. Strategies to address health
system factors and health worker perceptions associated with these practices are needed.
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Background
Global efforts to control malaria have recently led to reduction in the overall disease burden, with mortality due to
malaria estimated to have declined from 985,000 in 2000
to 660,000 deaths in 2010 [1]. Lower malaria prevalence
has therefore been reported from several sub-Saharan
African countries, including Tanzania [2,3]. In spite of this
decrease, malaria remains a leading public health problem
in many areas of sub-Saharan Africa, especially in children
under five years of age who remain most at risk of frequent
and severe malaria episodes with high mortality.
The introduction of artemisinin-based combination
therapy (ACT) has improved malaria case management
substantially. However, development and spread of ACT
resistance may have drastic consequences for the recent malaria control achievements. For this reason
it has become increasingly important to change from
symptom-based presumptive treatment to parasitological confirmation of malaria infection before initiation of
anti-malarial treatment. The use of parasite-based diagnosis will allow better targeting of anti-malarial drugs, and
also provide an opportunity for other causes of fever to be
identified and appropriately treated [4]. Therefore, WHO
now recommends that anti-malarial treatment be confined
to laboratory confirmed cases only [5], and the availability
of rapid diagnostic tests (RDTs) offers a good opportunity
to extend parasitological confirmation of malaria infection
to peripheral areas where quality microscopy cannot be
guaranteed [6,7].
The advantages offered by RDTs are well known [6,8,9]
although adherence to test results has been a challenge.
Several studies have reported poor adherence to RDT
negative test results [10-12], and underutilization of testing facilities [13,14], while other studies have shown opposite results with high utilization of RDTs and good
adherence to negative test results [15-19]. Importantly, in
the latter studies, overall health outcome of fever patients
also improved after RDT use, probably because of identification and management of non-malarial fevers. The discordant findings on adherence to RDT results underscore
the need to identify and address factors for non-adherence
in order to optimize the impact of RDTs.
It has been shown that perceptions of health service
providers are important in determining their prescription practices [20,21]. In some instances, health service
providers have reported “feeling under pressure” to prescribe anti-malarial drugs to patients with RDT negative
results, which suggests that patient perceptions and attitudes may also affect prescription behaviour [20,22].
The National Malaria Control Programme (NMCP) in
Tanzania has just completed rolling out malaria RDT to
ensure universal parasite-based diagnosis of all fever patients attending primary health care (PHC) facilities. With
the conflicting findings of the impact of RDT use in mind
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it is critical to identify factors affecting compliance in the
local setting in order to develop context specific interventions and maximize the benefits of RDT roll out. This
study therefore aimed to assess the present use of malaria
diagnostics at PHC facilities in Kibaha District, Tanzania,
and health workers’ as well as patients’ perceptions about
malaria diagnosis using RDT. The study also addressed
prescription behaviour and identification of factors affecting adherence to test results.

Methods
Setting of the study

This cross-sectional survey was conducted in Kibaha District, Coast Region, Tanzania. In this region malaria transmission is perennial, with peaks towards the end of the
long and short rains, that is May-July and DecemberJanuary, respectively. Plasmodium falciparum is the dominant malaria species. Artemether-lumefantrine is first-line
treatment for uncomplicated malaria since 2006. RDT implementation, using combo tests with a combination of
histidine-rich protein 2 (HRP2) and parasite lactate dehydrogenase (pLDH) to detect both falciparum and nonfalciparum species, was introduced in November 2009.
Sample and sampling process

At the time of the study there were 32 existing public
health facilities in Kibaha District (urban and rural). The
inclusion criteria were health facilities at peripheral level
offering services to the general public. The exclusion criteria were facilities at higher levels of care, and those belonging to government institutions, private or religious
organisations. A total of seven health facilities were excluded from sampling due to the higher level of health
care (one regional hospital and one health centre/district
hospital) or belonging to government and religious institutions (five dispensaries) serving special groups of patients. From the remaining 25 eligible facilities, ten were
selected by ballot. One of these facilities was a health
centre with in-patient facilities, while the remaining nine
were dispensaries offering out-patient services only.
Health service providers were interviewed after giving
verbal informed consent. Exit interviews were held on
two consecutive days at each study site with all patients
aged three months and above, and/or their guardians,
presenting with fever or history of fever after giving their
verbal consent. The interviews were conducted by two
postgraduate students from the University.
Data collection

Health care providers were interviewed using questionnaires with both open and closed questions to collect information on their knowledge and perception, and
prescription behaviour in relation to malaria RDTs. Exit
interviews were also conducted with fever patients or, in
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case of children, their caretakers to collect information
about their knowledge and attitudes towards malaria
testing. Patients’ presenting symptoms, malaria diagnostic tests performed, results, and prescribed drugs were
retrieved from their case notes and recorded onto case
record forms (CRF) developed for the purpose of this
study. In addition a health facility inventory was undertaken to collect information on staffing, availability of
supplies and equipment, including RDTs, microscopes
and anti-malarial drugs, as well as routine statistics on
total out-patient attendance, patients with fever, patients
tested for malaria, patients with positive results and
anti-malarial drug prescriptions over a 12-month period
(August 2010-July 2011).
Data analysis

Data were entered using EpiData 3.1 and statistical analysis was done using SPSS 17 statistical software. Descriptive analysis of the availability of malaria diagnostics
and ACT was assessed at health facility level, while exposure to training and supervision was analysed at
health worker level. To assess the performance of the
new RTD policy in terms of testing rates and antimalarial prescription rates, analysis was at patient level
and the X2 test was used, with a p-value of <0.05 considered statistically significant. Adherence to malaria test
results was analysed using logistic regression. Analysis of
both health workers’ and patients’ knowledge and perceptions was done after coding the open-ended responses into categories.
Ethical approval

Ethical approval for the study was provided by the Research and Publication Committee of the Muhimbili
University of Health and Allied Sciences. Verbal informed consent was obtained from patients or their
caretakers and health workers involved in the study.

Results
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A total of 20 of 114 (18%) health workers were interviewed. Twelve (60%) had clinical training background
and eight non-clinical. The clinicians included two assistant medical officers (AMO) with advanced diploma in
clinical medicine, nine clinical officers (CO) with diploma
and one certified assistant clinical officer (ACO). The
non-clinicians included three nurse midwives, three public
health nurses, one nurse assistant and one medical attendant. Health workers with clinical background were responsible for 157/195 (81%) of the prescriptions. The main
reasons given for involvement of non-clinicians in prescribing were shortage or absence of clinicians.
Eighteen (90%) of the health workers reported that
they had been trained previously on RDT use. The training ranged from one to five days and included causes of
fever, symptoms of malaria, performance and interpretation of RDT as well as management of patients with
positive and negative RDT results.
A total of 195 patients, including 115 (59%) females
and 80 males (41%), or their care takers/guardians in
case of children, underwent exit interviews. Some 87
(45%) were children under five years of age. All patients
presented with fever or history of fever. Other common
symptoms included cough/chest symptoms, cold symptoms, headache and malaise (Table 1). Cold symptoms,
diarrhoea and skin rash were more frequent in children
under five years, while headache and malaise were more
frequent in those above five years of age. Eighty patients
had a diagnosis recorded in the CRF. The most commonly recorded diagnosis was malaria (54%), followed
by respiratory tract infection (10%), skin/wound infections (8%) and genital/urinary tract infection (6%).
Malaria diagnosis and prescription practices

One hundred and sixty-eight patients (86%) were seen in
health facilities with available parasite-based diagnostics
and 27 (14%) in facilities without testing opportunities
(Figure 1). The overall parasite-based testing rate was
63% (105/168), i. e, 66% (53/80) in facilities equipped

Profile of health facilities, health workers and patients

The ten selected study sites (nine dispensaries and one
health centre) had in total 114 staff members, of whom
55 (48%) were nursing staff, 30 (26%) had clinical training and 29 (25%) belonged to other cadres (laboratory
personnel, health officers and medical attendants). The
health centre with in-patient facilities had 15 clinicians,
whereas the remaining nine facilities had between one
and three clinicians.
Nine of ten health facilities reported RDT stock-outs
at some point since their introduction. Eight study sites
were equipped with parasite-based diagnostics at the
time of survey, of which five used RDTs and three microscopy. Six health facilities had the first-line antimalarial drug in stock at the time of survey.

Table 1 Patients’ presenting symptoms (%)
Variable

<5 years >5 years All patients p-value

Number of patients

87

108

Fever

87 (100)

108 (100) 195 (100)

195

Cough/chest symptoms

41 (47.1)

48 (44.4)

89 (45.6)

0.71

Flu-like symptoms

36 (41.1)

15 (13.9)

51 (26.2)

0.00

Headache

2 (2.3)

35 (32.4)

37 (19)

0.00

Generalized body malaise 1 (1.1)

20 (18.5)

21 (10.8)

0.00

Diarrhoea

15 (17.2)

7 (6.5)

22 (11.3)

0.02

Vomiting

13 (14.9)

8 (7.4)

21 (10.8)

0.09

Skin rash

13 (14.9)

6 (5.6)

19 (9.7)

0.03

Abdominal pain

4 (4.6)

13 (12.0)

17 (8.7)

0.07
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Figure 1 Testing rates and prescriptions of anti-malarial drugs and antibiotics.

with RDT and 59% (52/88) in those with microscopy,
and the overall malaria positivity rate was 30% (31/105).
There were more positive cases in the RDT tested group
than in the microscopy group (38 vs 21%, p = 0.05).
Parasite-based testing was more common in children
below five years of age than those above five years although positivity rates did not differ (Table 2).
Anti-malarial drugs were prescribed to all 31 (100%)
patients with positive RDT/microscopy results and to
10/74 (14%) of negative patients (Figure 1). Among nontested patients, anti-malarial drugs were given to 25/90
(28%), with a higher prescription rate in facilities without
parasite-based diagnostics. Due to stock-outs of ACT in
some of the facilities, 18% of patients treated with antimalarial drugs were prescribed non-ACT (quinine or
sulphadoxine-pyrimethamine). Among the 66 patients
that received anti-malarial drugs, 35 (53%) were also
prescribed antibiotics, whereas 113 (88%) of patients
without an anti-malarial prescription were given antibiotics. Only 15 patients (8%) received prescriptions that
did not include an anti-malarial drug or an antibiotic.
There was no significant difference in the prescription of
antibiotics between children under five years of age and
older children and adults (80 vs 72%, p = 0.12). Prescription of antibiotics was higher among patients who tested
negative for malaria than those with positive results (81
vs 39%, p < 0.01), and among those not tested compared
to those tested for malaria (84 vs 69%, p = 0.01). Antipyretics were given to 159 (82%) patients either alone or in

combination with anti-malarial drugs and/or antibiotics.
Eighty-two patients (42%) were also prescribed other
drugs such as anti-helminths, multivitamins, anti-fungals,
iron supplements, etc.
Adherence to results of diagnostic tests was described as a situation where the patient was tested, had
positive results and was treated with anti-malarial
drugs; or the patient had negative results and was not
treated with anti-malarial drugs, and overall adherence
Table 2 Parasite-based malaria testing and prescription
rates (%) with anti-malarial drugs by age group
Patient category

<5 years >5 years All patients p-value

Number of patients

87

108

195

Patients tested for malaria 57 (65.5)

48 (44.4)

105 (53.8)

0.01

Patients with positive
results

17 (29.8)

14 (29.2)

31 (29.5)

0.94

Patients with negative
results

40 (70.2)

34 (70.8)

74 (70.5)

1.0

Malaria positive patients
prescribed anti-malarial
drugs

17 (100)

14 (100)

31 (100)

1.0

Malaria negative patients
prescribed anti-malarial
drugs

5 (12.5)

5 (14.7)

10 (13.5)

0.78

Non-tested patients

30 (34.5)

60 (55.6)

90 (46.2)

0.01

Non-tested patients
prescribed anti-malarial
drugs

6 (20.0)

19 (31.7)

25 (27.8)

0.24

Mubi et al. Malaria Journal 2013, 12:293
http://www.malariajournal.com/content/12/1/293

was 90.5%. In a multivariate analysis where several factors were included (health worker category, presence
of vomiting, diarrhoea, headache, cough/chest pain
and malaise), the model was able to account for 30% of
adherence, and presence of vomiting and headache
had significant contribution with an estimated odds ratio of 11.4 (95% Confidence interval (CI): 1.65-71.5)
and 6.4 (95% CI: 1.1-35.8), respectively. The other factors were not statistically significant although removing them from the model lowered its contribution in
adherence to 20%, suggesting that they are probably
confounding factors.
A review of routine health facility records for the previous 12 months revealed that data were not compiled
on a regular basis. In facilities with complete data, testing rates were high during the low transmission seasons
(>80%) and varied considerably during high transmission
seasons (15-100%). The proportion of over-prescription
with anti-malarial drugs was higher than observed in the
cross-sectional survey.
Perceptions of health workers and patients about malaria
diagnosis and treatment

Twenty health workers were interviewed, and according to them the main advantages of using RDTs
were ease of use (14/20; 70%), taking a shorter time to
produce results (11/20; 55%), and no need for electricity (6/20; 30%). Other advantages included helping to
target treatment, confirm/rule out malaria, accurate/
specific and patient satisfaction. The main disadvantage mentioned was false negative/inaccurate results
(14/20; 70%) and others included lack of trust by patients, test remaining positive after treatment, tests not
able to quantify parasites, negative results in patients
with severe symptoms and invalid results (control band
non-reactive).
Table 3 presents responses by the 18 health workers
previously trained on RDT use to selected questions
asked in the interview. The majority of health workers
(13/18; 72%) had confidence in RDT results. Those who
had confidence gave the following reasons: RDTs have
been approved by relevant authorities, they are sensitive/
specific, the results are consistent with symptoms, RDT
results match transmission season and positive patients
respond to anti-malarial drugs. Conversely, those who
did not have confidence in RDTs mentioned false negative results, negative results in patients with symptoms,
test remaining positive after treatment and good response to anti-malarial treatment in patients with negative results as their reasons. Seven (39%) health workers
said patients do not trust RDT results and gave reasons,
such as patients assuming that any fever is due to malaria (six), positive results reported at private health facilities (four) and suspecting they are tested for HIV (one).
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Table 3 Health workers’ (HW) attitudes towards RDTs and
prescriptions of anti-malarial drugs
Questions addressed to health workers

Clinical

Non
clinical

All
HW

N

N

N

Do you have confidence in RDT results?
Yes

8

5

13

No

3

2

5

Do you sometimes prescribe anti-malarial
drugs to patients with negative results?
Yes

7

5

12

No

4

2

6

Yes

10

3

13

No

1

4

5

Do patients sometimes demand antimalarial drugs when results are negative?

Do patients trust RDT results?
Yes

7

4

11

No

4

3

7

When asked if they sometimes prescribe anti-malarial
drugs to RDT negative patients, 12/17 (67%) of the health
workers admitted to such practice. Eleven of these said
that the rationale for prescribing anti-malarial drugs to
RDT-negative patients was because the clinical symptoms
were suggestive of malaria and one mentioned persistent
symptoms in patients with negative results. Five health
workers said patients sometimes demand anti-malarial
drugs despite negative results, although only one admitted
to prescribing due to patient demand.
Regarding knowledge about RDTs from the patient/
caretaker perspective, 84 (43%) indicated that they had
heard about RDTs, of whom 80 (95%) reported the health
facility to be the main source of information. Overall 100%
of patients with positive and 92% with negative RDT results said they were satisfied with the results. Trusting the
health worker and the patient getting better after treatment were the main reasons for patient satisfaction, and
hence trust of RDT results. Those not satisfied reasoned
that they did not expect negative results and they were
given positive results at a private dispensary.
Patients’ views of the advantages of using RDT included being fast, being able to confirm the diagnosis
and producing reliable results. Other advantages were
related to ease of use of the test, mainly the fact that
there is no need for electricity or equipment, making it
possible to use even in peripheral health facilities.

Discussion
One year after introduction of RDTs as parasite-based
malaria diagnostic tool in Kibaha District, Coast Region,
Tanzania, this study found low testing rates, stock-outs
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of both RDTs and ACT, and non-adherence to negative
test results.
Relatively, low testing rates were found in health facilities with parasite-based diagnostics, which was more pronounced in older patients than in children below five
years of age. Stock-outs of RDTs together with staff shortage were reported as reasons for not using RDTs. In a
study in Kenya, partial deployment of RDTs was said to
lead to low testing rates of below 30%, although the rates
did not exceed 54% even when testing facilities were available [14]. Another study reported under-use of testing facilities especially among older children and adults, which
was unexpected as the previous recommendation was to
treat all fevers in under-fives as malaria and test those
above five years of age [18]. Lack of standard criteria for
those who should be tested was also identified as responsible for the low testing rates and non-utilization of results
[20]. New guidelines require testing of all patients
suspected to have malaria, irrespective of age, after it was
established that withholding anti-malarial drugs from
parasite-negative children is safe [23-25].
Prescription of anti-malarial drugs for patients with
negative parasite-based test results and those not tested
is still practiced in areas where RDTs have been introduced. These two practices are contrary to the recommendations by WHO, which require universal testing of
all patients suspected to have malaria and treatment
with anti-malarial drugs be confined to parasitologically
confirmed cases [5,7]. In other areas health workers have
also continued prescribing anti-malarial drugs to RDTnegative patients [11,20,26,27]. However, the rate of
over-prescription observed in this study is much lower
than in earlier studies and corresponds better with rates
observed in Tanzania [15,17]. Lower rates could be a reflection of experience and acceptance of RDTs, and better training and implementation of the RDT programme.
Stock-outs of ACT defined as running out of ACT for
some periods before the next supply is received were
also observed in some health facilities, which could be
due to overuse of ACT in the treatment of patients with
negative RDT results, or health system factors such as
delays in procurement or underestimating requirements.
This led to the prescription of non-ACT, contrary to national guidelines advocating the use of ACT as first-line
anti-malarial drugs [28].
The majority of health workers had been trained on
RDT use and in general health workers had good understanding of RDTs although a few mentioned that RDTs
are sensitive and specific and improve rational use of
drugs. Their non-adherence to test results could be due to
prior training and experience, which leads to overemphasis on malaria, and limited capabilities to make alternative
diagnosis. Similar findings have been reported in Tanzania
and Cameroon [21,29] where justification given for
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treating patients with negative results are based on previous guidelines and experience with the use of antimalarial drugs. In other studies, while health workers
reported that RDT results were reliable, very few used
them in case management, leading to overprescription
among RDT-negative patients [12,20]. Previous malaria
diagnosis and treatment guidelines stated that a negative
test result does not rule out malaria, so clinical judgement
should be used [28,30]. Proper training of health workers
and equipping health facilities with the capacity to manage
patients with both positive and negative RDT results will
ensure that health workers have the capacity to identify
and treat non-malarial causes of fever, an important factor
in adherence to results [7].
Although a few health workers highlighted that sometimes patients with negative results demand anti-malarial
prescriptions, the majority of patients trusted the results,
mainly because they trust the health workers and get better after treatment, making it unlikely that they will demand anti-malarial drugs. A similar finding was reported
in north-eastern Tanzania [22] where patients were not
observed to demand anti-malarial prescription.
Having been given positive test results in private dispensaries was mentioned by both health workers and patients as a reason for lack of trust. This was observed in
peri-urban areas where patients consult private clinics
first, and go to government facilities for subsidized drugs
when results are positive (personal observation). Informal discussions with health workers show that private
health facilities give positive results to justify the money
paid by patient for testing, to create an opportunity to
sell anti-malarial drugs to the patient and, in the case of
incompetent laboratory personnel, to avoid the danger
of missing a true malaria infection. In the Cameroon
study [29], health workers reported to give positive results to please the patient so that they feel they have not
wasted their money on a test, as well as safeguard their
reputation as a negative result would mean the health
worker is incompetent.
It was also observed that prescription of antibiotics was
higher among patients with negative results and those not
tested. The rates observed in this study are higher than
those reported in a previous study in the same area and in
Zanzibar [15,31] but similar to those reported in another
study [17]. Whether the antibiotic prescriptions were justified or not is outside the scope of this study. Still, there is
a raising concern that the use of malaria diagnostics could
lead to overprescription of antibiotics among patients with
negative test results due to the lack of diagnostics and insufficient understanding of aetiologies of non-malarial fevers. Training of health workers in malaria diagnosis using
RDTs should include training on identification of other
causes of fever, including for example the provision and
use of simple devices such as the respiratory rate timers
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for pneumonia used in integrated community case management (iCCM) in Uganda [32].
Limitations

The sample size for the health workers’ interview was
too small to allow further analysis of associations between variables such as education of health worker and
prescription practice. The data collection method used,
i. e, interviews with open-ended questions, did not offer
an opportunity for cross-tabulating the responses provided. In-depth interviews could have provided a better
assessment of perceptions and attitudes of both health
workers and patients. The relatively good performance
of health workers could partly be due to the Hawthorne
effect. The availability of health facility records showing
prescription practice over a longer period of time could
allow validation of data obtained from exit interviews,
when health workers knew that their prescription practices were being assessed. However, the value of such
data was limited due to poor record keeping as seen in
this study. Despite these limitations, the use of data from
multiple sources including patients, health workers and
health facility inventory allowed for a general assessment
of prescription practices.

Conclusion
Findings from this study show that overprescription with
anti-malarial drugs is still practiced in an area of Tanzania
where universal testing with RDTs have been introduced as
official policy since treatment of RDT-negative patients and
treatment based on clinical diagnosis without testing remains. The use of malaria diagnostics was also associated
with higher prescription of antibiotics among patients with
negative test results. Factors responsible for these practices
include system factors such as non-availability of testing facilities, limited capacity to diagnose other causes of fever,
staff shortage, and health workers perceptions about the
importance of malaria and test results. In order to make
RDTs have an impact in reducing unnecessary use of antimalarial drugs and improve patient management, there is a
need to address the identified factors by ensuring regular
supply of testing facilities, retraining of health workers on
RDTs and the importance of adhering to test results, training and support in the diagnosis and management of other
causes of fever and close supervision.
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